Contineum Therapeutics, Inc. (CTNM)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
14. 23
+0.22
+1.5703%
$
544.72M Market Cap
- P/E Ratio
- Div Yield
145,200 Volume
- Eps
$ 14.01
Previous Close 
Want to track CTNM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Contineum Therapeutics, Inc. (CTNM) Statistics
Valuation metrics
Market Cap 544.72M
Enterprise value 518.8M
Trailing P/E (ttm) -7.3
Forward P/E -
PEG ratio 1.74
Price/Sales (ttm) -
Price/Book (mrq) 2.12
Enterprise Value/Revenue -
Enterprise Value/EBITDA -8.93
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 135.84K
Average volume (90 days) 211.01K
Price summary
52-Week low 3.8
52-Week high 16.91
Beta -
50-Day moving average 13.81
200-Day moving average 13.37
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.22%
Return on equity -0.27%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.57
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.6
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 38%
Book value per share (mrq) 6.7
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
